Short answer
Tvardi Therapeutics, Inc. (TVRD) filed an 8-K current report with the SEC on July 17, 2026 reporting Item 8.01 (Other Events). ATM offering increased by up to $9.69 million, expanding potential equity financing capacity.
Tvardi Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- ATM offering increased by up to $9.69 million, expanding potential equity financing capacity
- $11.0 million gross proceeds from 3,110,769 shares sold during prior twelve-month period
- Baby-shelf limit tied to $62.21 million non-affiliate market value and 12,441,789 shares
- No additional common stock sales under the existing Sales Agreement Prospectus after July 17, 2026
- Potential dilution and financing runway implications for existing shareholders
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Tvardi Therapeutics, Inc. 8-K filings
Get the next TVRD 8-K as it lands
Follow TVRD for push alerts, or ask the research agent what this filing means.